Rosaria Tucci

Rosaria Tucci

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CACarlotta Agostini
Carlotta Agostini
SBSimone Buccianti
Simone Buccianti
MRMatteo Risaliti
Matteo Risaliti
Laura FortunaLaura Fortuna
Laura Fortuna
LTLuca Tirloni
Luca Tirloni
Gian Luca GraziGian Luca Grazi
Gian Luca Grazi
Liver transplantation (LT) is the treatment of choice for liver failure and selected cases of malignancies. Transplantation activity has increased over the years, and indications for LT have been widened, leading to organ shortage. To face this condition, a high selection of recipients with prioritizing systems and an enlargement of the donor pool were necessary. Several authors published their case series reporting the results obtained with the use of marginal donors, which seem to have progressively improved over the years. The introduction of in situ and ex situ machine perfusion, although still strongly debated, and better knowledge and treatment of the complications may have a role in achieving better results. With longer survival rates, a significant number of patients will suffer from long-term complications. An extensive review of the literature concerning short- and long-term outcomes is reported trying to highlight the most recent findings. The heterogeneity of the behaviors within the different centers is evident, leading to a difficult comparison of the results and making explicit the need to obtain more consent from experts.

27 January 2021 in World Journal of Gastrointestinal Surgery
Verified
Journal Article
Open access
FMFilippo Melli
Filippo Melli
IBIlenia Bartolini
Ilenia Bartolini
MRMatteo Risaliti
Matteo Risaliti
RTRosaria Tucci
Rosaria Tucci
MRMaria Novella Ringressi
Maria Novella Ringressi
Amedeo AmedeiAmedeo Amedei
Amedeo Amedei
Colorectal cancer is a common tumor with a quite high-related mortality. Despite the used curative treatments, patients will develop cancer recurrence in up to 50% of the cases and/or other primary neoplasms. Although most of the recurrences are discovered within 3 years from the first treatment, a small percentage is found after 5 years. The early detection of recurrence is crucial to allow further therapies improving patients’ survival. Several follow-up programs have been developed but the optimal one is far from being established. To evaluation of potential prognostic factors for timing and patterns of recurrence in order to plan tailored follow-up programs. Perioperative and long-term data of all consecutive patients surgically treated with curative intent, from January 2006 to June 2009, for colorectal adenocar-cinoma, were retrospectively reviewed to find potential prognostic factors associated with: (1) Recurrence incidence; (2) Incidence of an early (within 3 years from surgery) or late recurrence; and (3) Different sites of recurrence. In addition, the incidence of other primary neoplasms has been evaluated in a cohort of patients with a minimum potential follow-up of 10 years. Our study included 234 patients. The median follow-up period has been 119 ± 46.2 mo. The recurrence rate has been 25.6%. Patients with a higher chance to develop recurrence had also the following characteristics: Higher levels of preoperative glycemia and carcinoembryonic antigen, highest anaesthesiologists Score score, occlusion, received a complex operation performed with an open technique, after a longer hospital stay, and showed advanced tumors. The independent prognostic factors for recurrence were the hospital stay, N stage 2, and M stage 1 (multivariate analysis). Younger ages were significantly associated with an early recurrence onset. Patients that received intermediate colectomies or segmental resections, having an N stage 2 or American Joint Committee on Cancer stage 3 tumors were also associated with a higher risk of liver recurrence, while metastatic diseases at diagnosis were linked with local recurrence. Neoadjuvant treatments showed lung recurrence. Finally, bigger tumors and higher lymph node ratio were associated with peritoneal recurrence (marginally significant). Thirty patients developed a second malignancy during the follow-up time. Several prognostic factors should be considered for tailored follow-up programs, eventually, beyond 5 years from the first treatment.

1 April 2022 in Journal of Minimal Access Surgery
Verified
Journal Article
Open access
MAMassimiliano Ardu
Massimiliano Ardu
DBDamiano Bisogni
Damiano Bisogni
ABAlessandro Bruscino
Alessandro Bruscino
RTRosaria Tucci
Rosaria Tucci
MFMassimo Falchini
Massimo Falchini
PPPaolo Prosperi
Paolo Prosperi
Background: The best operative approach to large hiatal hernias still remains controversial between suture cruroplasty and prosthetic hiatal herniorrhaphy. This study aims at analysing results from a single institution in Italy in terms of subjective and objective outcomes. Methods: Retrospectively collected data of all patients that underwent laparoscopic hiatal hernia repair since 2011 were considered. Sixty-five patients were included overall; 17 of them fit the criteria of large hiatal hernia. Follow-up (FU) was assessed by visit, questionnaires and X-ray imaging. Results: No major complications occurred in the post-operative course. No patient was lost during the FU period. Out of all the patients included, 13 agreed to have an X-ray with water-soluble contrast. The questionnaires showed a 76.5% rate of satisfaction (13 patients), and the recurrence rate demonstrated by radiology was 29.4% (five patients). There were no major mesh-related complications. Conclusion: The best operative approach for large hiatal hernias remains far from standardised: There is a lack of evidence on the use of a mesh for this kind of surgery as well as substantial controversy over the definition of what a giant hiatal hernia is. Nevertheless, the results from this study and the main studies in the literature seem to be encouraging in improving giant hiatal hernia repair outcomes.

1 April 2020 in The American Surgeon™
Verified
Journal Article
Open access
PDF file
MAMassimiliano Ardu
Massimiliano Ardu
GAGiovanni Alemanno
Giovanni Alemanno
PPPaolo Prosperi
Paolo Prosperi
RTRosaria Tucci
Rosaria Tucci
VIVeronica Iacopini
Veronica Iacopini
AVAndrea Valeri
Andrea Valeri

15 January 2021 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
FCFrancesco Coratti
Francesco Coratti
RTRosaria Tucci
Rosaria Tucci
CACarlotta Agostini
Carlotta Agostini
GBGiuseppe Barbato
Giuseppe Barbato
AMAndrea Manetti
Andrea Manetti
FCFabio Cianchi
Fabio Cianchi

1 March 2018
Verified
Journal Article
Closed access
APAnnunziata Panebianco
Annunziata Panebianco
RLRita Laforgia
Rita Laforgia
AVAnnalisa Volpi
Annalisa Volpi
RMRossana Mancarella
Rossana Mancarella
GCGiuseppe Carbotta
Giuseppe Carbotta
NPNicola Palasciano
Nicola Palasciano